Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory mantle cell lymphoma: Extended follow-up from BRUIN Meeting Abstract


Authors: Lewis, D. J.; Wang, M. L.; Shah, N. N.; Jurczak, W.; Zinzani, P. L.; Eyre, T. A.; Cheah, C. Y.; Ujjani, C. S.; Koh, Y.; Izutzu, K.; Gerson, J. N.; Flinn, I.; Tessoulin, B.; Alencar, A. J.; Ma, S.; Lech-Maranda, E.; Rhodes, J.; Patel, K.; Woyach, J.; Lamanna, N.; Wang, Y.; Tam, C.; Seymour, J. F.; Munir, T.; Nagai, H.; Hernandez-Ilizaliturri, F.; Kumar, A.; Zelenetz, A.; Jain, P.; Nair, B.; Tsai, D. E.; Balbas, M.; Walgren, R. A.; Abada, P.; Wang, C.; Zhao, J.; Mato, A. R.
Abstract Title: Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory mantle cell lymphoma: Extended follow-up from BRUIN
Meeting Title: 63rd Annual Scientific Meeting of the British Society for Haematology
Journal Title: British Journal of Haematology
Volume: 201
Issue: Suppl. 1
Meeting Dates: 2023 Apr 23-25
Meeting Location: Birmingham, United Kingdom
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2023-04-01
Start Page: 108
End Page: 109
Language: English
ACCESSION: WOS:001049283000178
PROVIDER: wos
DOI: 10.1111/bjh.18720
Notes: Meeting Abstract: BSH23-PO81 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    784 Zelenetz
  2. Anita Kumar
    198 Kumar
  3. Anthony R Mato
    236 Mato